Although further studies remain necessary, using indocyanine green fluorescence imaging during breast cancer surgery and breast reconstruction appears to appreciably lower costs, both by eliminating the need for technetium Tc 99m and by reducing perfusion-related complications.
Goldhawk-White et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: